Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients cardiovascularbusiness.com/topics/structu…

Good options always if feasible for high risk patients. TMVR ViV Lantz, MD Ahmad Masri

Interesting study from France. ViV vs redo isolated AVR. Reminds me of PARTNER 2. Lines cross at 2 years for composite and isolated mortality.

Great work in JACC today on CABG vs PCI for multivessel CAD in diabetics. Take away: CABG is superior strategy with a LARGE survival advantage. Admin data but solid analytic approach. Is CABG being underused in diabetics? David J. Cohen, MD, MSc MIЯVΛƬ #IC Dr. Gilbert Tang Less-Is-More Cardiologist

Heparin vs bival cost comparison. This concludes bival is a safe and cost effective alternative to heparin, with a much more stable dosing and increased reliability in monitoring. #ecmo

There are 5 goals in mitral repair: 1) Preserve leaflet mobility. 2) Restore leaflet coaptation. 3) Reduce posterior leaflet height (“height" refers to the distance from the base of the leaflet at the annulus to the leaflet free margin. 4)Reduce annular dilation. 5) Prevent SAM.

Happy to share the news of our first successful TAMBE implant for TAAA ⁦Division of Vascular Surgery at IUSM⁩ ⁦IU School of Medicine Department of Surgery⁩ ⁦IU Health⁩ ⁦IU School of Medicine⁩.Great team effort at best ⁦Andres Fajardo⁩ ⁦S. Keisin Wang⁩ , Joel Corvera , Ashley Gutwein ⁦Gore⁩

Severe 23 sapien TAVR AS placed 1 year ago- deep implant with moderate PVL- mean grad 105, peak 174 (valve ID 18.8 on CT)- dialysis related valve failure- Shock on small dose nor epinephrine.

Structural Heart Fellowship opening starting July 2021 OHSU Knight Cardio - center for major clinical trials/early feasibilty studies and lots of structural procedures. Interested candidates- can DM in inbox please. Thank you. Ahmad Masri Punag Divanji Stacey Howell @lucyqlin3 Saurav Chatterjee

Discussion of treatment options should focus less on making right & wrong decisions and more on actions & consequences (Joe Bavaria, MD). Elaborating on different scenarios may be more helpful when making plans in the face of uncertainty. #lifelongcare 20mm #TAVR 3y ago -> 23mm #SAVR

Can we put the "pump head" urban myth to rest? No diff in late cognitive decline for CABG vs PCI Interestingly, sub-analysis found OPCAB WORSE than on-pump Association of CABG vs PCI With Memory Decline in Older Adults Undergoing Coronary Revascularization ja.ma/3eYe4bd

Looking forward to it and OHSU being one of the live case sites Joaquin E. Cigarroa MD FACC MSCAI Scott Chadderdon Dr. Cristina Fuss Lantz, MD OHSU Knight Cardio @OHSUCardFellow

This is the way.

The first #TAVR live case of #TVT2021 starts at 8:00 AM ET. Featuring a bioprosthetic valve failure case from OHSU News performed by Firas Zahr, Howard Song, Joshua Vogt Scott Chadderdon Harsh Golwala Lantz, MD and moderated by Adnan Chhatriwalla Dr. Nicolas M Van Mieghem ow.ly/hJjq50FyWOb

Hot off the press from TVT registry (over 400K pts) presented by Joe Bavaria at Ancona, Italy meeting. Real-world data shows 11.3% 1yr TAVR mortality for all pts and 5% 1yr TAVR mortality for low-risk pts. The Society of Thoracic Surgeons UCSF Heart & Vascular Care TCTMD

Largest and only randomized trial comparing sternotomy vs. minimally invasive mitral surgery. Fun discussing this topic with Jo Chikwe thanks to Medscape and cardio-research.com